Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest update is out from Bausch + Lomb Corporation ( (BLCO) ).
Bausch + Lomb announced that its exploration of taking the company private through a sale has concluded without a transaction, following a regulatory request in December 2024. Despite this, the company remains committed to achieving full separation from Bausch Health Companies Inc. and continues to focus on its growth strategies, having raised its 2024 revenue guidance and preparing to report its financial results in February 2025.
More about Bausch + Lomb Corporation
Bausch + Lomb is a global leader in the eye health industry, offering a wide range of approximately 400 products including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, and surgical devices. Founded in 1853, the company has a significant global presence with around 13,000 employees and operations in nearly 100 countries, headquartered in Vaughan, Ontario.
YTD Price Performance: -1.39%
Average Trading Volume: 481,026
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.25B
For detailed information about BLCO stock, go to TipRanks’ Stock Analysis page.
